Skip to main navigation Skip to search Skip to main content

Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: Results from the randomized phase III BRISK-PS study

  • Josep M. Llovet
  • , Thomas Decaens
  • , Jean Luc Raoul
  • , Eveline Boucher
  • , Masatoshi Kudo
  • , Charissa Chang
  • , Yoon Koo Kang
  • , Eric Assenat
  • , Ho Yeong Lim
  • , Valerie Boige
  • , Philippe Mathurin
  • , Laetitia Fartoux
  • , Deng Yn Lin
  • , Jordi Bruix
  • , Ronnie T. Poon
  • , Morris Sherman
  • , Jean Frédéric Blanc
  • , Richard S. Finn
  • , Won Young Tak
  • , Yee Chao
    • Rana Ezzeddine, David Liu, Ian Walters, Joong Won Park

Research output: Contribution to journal › Article › peer-review

533 Scopus citations

Fingerprint

Dive into the research topics of 'Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: Results from the randomized phase III BRISK-PS study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science